WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, April 30, 2024.
The schedule for the press release and conference call/webcast is as follows: | |
¢ Q1 2024 Press Release: | April 30, 2024 at 7:00 a.m. ET |
¢ Q1 2024 Conference Call: | April 30, 2024 at 8:00 a.m. ET |
¢ Domestic Dial-In Number: | 877-407-3042 |
¢ International Dial-In Number: | 201-389-0864 |
¢ Conference ID Number: | 13745743 |
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13745743.
The live webcast with slides can be accessed at Investor.Incyte (NASDAQ:INCY).com and will be available for replay for ninety days.
About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.
For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook (NASDAQ:META), YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240411369652/en/
Media
media@incyte.com
Investors
ir@incyte.com
Source: Incyte